GlaxoSmithKline's spinoff plan is here—and it may not be limited to consumer health

GlaxoSmithKline's spinoff plan is here—and it may not be limited to consumer health

Source: 
Fierce Pharma
snippet: 

GlaxoSmithKline made clear it intended to spin off its consumer health joint venture with Pfizer when the partners first unveiled the deal. Now, the British drugmaker has officially started a two-year journey toward that split, which may take prescription dermatology along with it.